FITting Non-invasive Tests in Lynch Syndrome Surveillance
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT06898996
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Fecal immunochemical test — OTHERDetects blood in stool
Study Details
The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.
Key Dates
- Start date
- Jul 10, 2025
- Status verified
- Apr 2026
- Primary completion
- Mar 1, 2029
- Completion
- Jul 1, 2029
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Non-invasive surveillance testEasily accessible, affordable and acceptable tests can be used to triage Lynch syndrome patients to colonoscopy
Primary Outcome Measure
Quantitative Measure of specificity [ Time Frame: baseline -12 months ]
Central Contacts
- Sonia Kupfer, MD(773) 834-1438
- Kristi Kearney, RN773-834-7414
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Chicago Medical Center | Chicago | Illinois | 60639 | |
| University of Michigan | Ann Arbor | Michigan | 48109 | |
| Columbia University | New York | New York | 10032 |
Find similar trials in Chicago, IL
By condition
By specialty
Related Studies
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesPHASE1/PHASE2 · Recruiting · Roswell Park Cancer Institute · Buffalo, New York
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal CancerRecruiting · Wake Forest University Health Sciences · Millville, Delaware